Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-031858

Chief Financial Officer acquired 2,340 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Trigilio Jeffrey Chief Financial Officer 2023-06-30 Grant or award +2,340 $9.08 $21,247 88,163 D
Loading xslF345X04/ownership.xml…